Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma

Published:2017-12-18 Issue:4 Volume:65 Page:e26896
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Guenther Lillian M.¹^ORCID,Rowe R. Grant¹,Acharya Patricia T.²,Swenson David W.²,Meyer Stephanie C.¹,Clinton Catherine M.¹,Guo Dongjing¹,Sridharan Madhumitha¹,London Wendy B.¹,Grier Holcombe E.¹,Ecklund Kirsten²,Janeway Katherine A.¹^ORCID

Affiliation:

1. Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Boston Massachusetts

2. Department of Radiology; Boston Children's Hospital; Boston Massachusetts

Funder

Fred Lovejoy Resident Research and Education Award

American Academy of Pediatrics Resident Research Grant

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.26896/fullpdf

Reference25 articles.

1. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity;Link;N Engl J Med,1986

2. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J Clin Oncol,2002

3. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects;Janeway;Lancet Oncol,2010

4. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate;Meyers;J Clin Oncol,2005

5. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial;Goorin;J Clin Oncol,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis;Cancer Epidemiology;2024-06

2. Histopathological Response to Neoadjuvant Chemotherapy in Patients With Enneking Stage II Conventional Osteosarcoma of Extremities: A Retrospective-Single Institution Study in Vietnam;Cancer Control;2024-01

3. Bone Neoplasms: Osteosarcoma and Ewing Sarcoma;Evidence-Based Imaging;2024

4. European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma;EJC Paediatric Oncology;2023-12

5. Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study;Frontiers in Oncology;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3